20 November 2017 / Paris, France


The event agenda's time zone is CET.

20 Nov 2017
08:30 – 13:00
Plenary Session

08h30 – 09h00 Registration, coffee 

09h00-09h10 Welcome - NeurATRIS

  • Philippe Hantraye - Director of MIRCen (CEA) and NeurATRIS 
    NeurATRIS : all neuroscience bricks for translational research

09h10 – 10h30 Session 1: Multidisciplinary academic expertise and platforms for translational neurodegenerative disease projects 

  • Brahim Nait Oumesmar, ICM - Leader of “Cellular and molecular approaches for myelin repair” team
    Innovation in Pre-Clinical Models of  Multiple Sclerosis
  • Anselme Perrier, I-Stem - Group leader of “Neurodegenerative diseases” team
    Human pluripotent stem cell neural derivatives for disease modelling and drug screening
  • Pierre Gressens, Hôpital Robert Debré - Director of “neuroprotection of developing brain” unit
    Targeting microglia to promote white matter neuroprotection and myelination
  • Anne-Catherine Bachoud-Lévi, CHU Henri Mondor - Head of Neurology department and Head of IMRB
    Cognitive endpoints in clinical trials: the example of Huntington’s disease 
  • Jean-Christophe Corvol, ICM - Director of Clinical Investigation Centre
    Towards precision medicine in Parkinson's disease: cohorts and databases in France

10h30 – 10h45 EATRIS

  • Anton Ussi - Operations & Finance Director
    In search of a predictive and productive pipeline – how can academia support the innovation process?

10h45 – 11h00 Coffee break

11h00 – 12h20 Session 2: Industrial point of view and needs 

  • Salah Dine Chibout, Novartis - Global Head Investigative and Regulatory Safety and Head Novartis Public Private Partnership
    IMI, the largest Private-Public Partnership in the world. How does it work? How to get involved?

  • Declan Jones, Johnson and Johnson - VP, Neuroscience Lead
    What is Pharma looking for from academic partners in neuroscience drug discovery?

  • Anne-Sophie Jean Deleglise, Merck Serono - Director of Medical Affairs: Neurology
    An example of academic - industry collaboration at Merck

  • Philippe Rideau, Nikon - General Manager
    Center of excellence Nikon - Nantes: a win-win partnership between UMR 703 and Nikon

12h20 – 13h00 Company pitches

  • AgenT - Jérôme Braudeau
  • Bio-Modeling Systems - Manuel Gea
  • Bioserenity - Samir Medjebar
  • Brainvectis - Jérôme Becquart
  • Gliotex - Ahmed Idbaih
  • Hybrigenics - Jean-Christophe Rain
  • IOCB - Jana Kenney
  • ManRos Therapeutics - Laurent Meijer
  • myBrain Technologies - Yohan Attal
13:00 – 13:40
13:00 – 13:40
Matchmaking B2B Session
13:40 – 14:20
13:40 – 14:20
Matchmaking - B2B Session
14:20 – 17:20
Matchmaking B2B Session
The event agenda's time zone is CET.